WEBINAR: Accelerating DCT Adoption – Integrated Partnering Is Key

Integrating the IRT system into the currently existing workflows of various sponsors is essential to making the most of the streamlined data output. Decentralized trials (also known as DCTs) are extremely challenging to run efficiently due to their siloed nature – every chapter of the process needs its own data entry and analysis, resulting in weeks of data compilation and analysis to ensure an accurate final data set. endpoint Clinical and partner Encapsia dive into the process of integration and discuss how a seamless workflow changes the effort profile of a trial for the better, as long as it is well understood and implemented.

Download this case study to learn:

  • How key advantages of real-time data allow sponsors to deal with any issues or alerts that require immediate response, thereby removing redundancies and inefficiencies.
  • The benefits of always having the latest and final data set from day one, without having to wait until the end of the trial to compile, organize, and query the data.
  • How site-focused, subject-first, dynamic technology supports multi-modal drug supply while enabling valuable research site relationships in DCT
  • Risk management for DCT –eClinical tools to automate data flow and gain real-time insights for patient safety, drug integrity, and a fully visible audit trail from distribution to dosing

Speakers

Temitope Keyes

Executive Director, Business Development Technology
encapsia

Temitope (Tope) Keyes brings 22 years of clinical R&D experience, which began on the sponsor side, with the majority of that primarily in the eClinical solutions space. She has a passion for technology and its ability to advance important research and successful trial execution. Her experience began in pre-clinical purchasing and clinical outsourcing roles at Astra-Zeneca and Sanofi, followed by almost 15 years in business development with the likes of ERT, Synteract, Datatrak, and Axiom Real-Time Metrics. Tope joined Cmed Technology in 2020.

Vincent Puglia

Senior Director, Strategic Alliances
endpoint

Vincent is a life-long operations and business management professional with a 24-year career across construction, environmental science, technology, and pharmaceuticals. Vincent provides leadership at the nexus of building relationships, innovating technology, and driving collaborative efforts to design, build and grow systems of all types and complexity in the real and digital world in the service of patients and clinical trials.

Mark Tomlinson

Senior Director, Technology Operations
encapsia

Mark Tomlinson has 30 years’ experience in supporting the delivery of clinical trials, with the last 20 years focused on client delivery and adoption of technologies such as EDC and eSource. Mark is a firm believer in the power of collaboration to appreciate the real needs of technology users and ensure any adoption brings true efficiencies and return on investment.

Contact Sales